Market cap:
$2.01B+$57.38M(+2.94%)Summary
- As of today (April 12, 2025), LGND market capitalization is $2.01 billion, with a rise of +$57.38 million (+2.94%) during the most recent trading session on April 11, 2025.
- Over the past year, LGND market cap has increased by +$548.21 million (+37.56%).
- LGND market cap is now -65.34% below its all-time high of $5.79 billion.
Performance
LGND Market cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Related metrics
Market cap Formula
Market Cap = Price ✕ Shares Outstanding
LGND Market cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | +2.9% | +2.9% | +0.8% | +3.0% |
| 1 m1 month | -1.4% | -1.4% | - | -1.5% |
| 3 m3 months | -2.4% | -1.9% | - | -2.5% |
| 6 m6 months | +3.7% | +1.3% | - | - |
| ytdytd | -1.8% | -2.7% | - | -1.9% |
| 1 y1 year | +37.6% | +28.1% | +7.4% | +37.2% |
| 5 y5 years | +44.9% | +20.6% | +20.1% | +12.7% |
LGND Market cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $2.15B | -6.6% | $1.86B | +7.9% |
| 3 m | 3-month | $2.40B | -16.3% | $1.86B | +7.9% |
| 6 m | 6-month | $2.49B | -19.5% | $1.86B | +7.9% |
| 1 y | 1-year | $2.49B | -19.5% | $1.24B | +61.8% |
| 3 y | 3-year | $2.49B | -19.5% | $864M | +132.5% |
| 5 y | 5-year | $3.47B | -42.1% | $864M | +132.5% |
| alltime | all time | $5.79B | -65.3% | $102M | +1859.5% |
Ligand Pharmaceuticals Incorporated Market cap History
| Date | Value |
|---|---|
| 2025 | $2.01B(-1.8%) |
| 2024 | $2.04B(+62.9%) |
| 2023 | $1.26B(+10.9%) |
| 2022 | $1.13B(-56.3%) |
| 2021 | $2.59B(+61.9%) |
| 2020 | $1.60B(-8.9%) |
| 2019 | $1.75B(-37.7%) |
| 2018 | $2.82B(-2.7%) |
| 2017 | $2.90B(+36.3%) |
| 2016 | $2.12B(-1.8%) |
| 2015 | $2.16B(+107.6%) |
| 2014 | $1.04B(-3.3%) |
| 2013 | $1.08B(+144.0%) |
| 2012 | $441.32M(+90.0%) |
| 2011 | $232.23M(+33.4%) |
| Date | Value |
|---|---|
| 2010 | $174.02M(-31.3%) |
| 2009 | $253.16M(-2.7%) |
| 2008 | $260.14M(-42.9%) |
| 2007 | $455.37M(-58.2%) |
| 2006 | $1.09B(+33.7%) |
| 2005 | $814.65M(-4.1%) |
| 2004 | $849.38M(-21.0%) |
| 2003 | $1.08B(+180.2%) |
| 2002 | $383.68M(-64.3%) |
| 2001 | $1.08B(+35.4%) |
| 2000 | $794.50M(+16.4%) |
| 1999 | $682.60M(+28.5%) |
| 1998 | $531.13M(+7.1%) |
| 1997 | $495.73M(+4.8%) |
| 1996 | $473.01M(+145.1%) |
| 1995 | $193.00M |
FAQ
- What is Ligand Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
- What is LGND market capitalization year-to-date change?
- What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
What is Ligand Pharmaceuticals Incorporated market capitalization?
The current market cap of LGND is $2.01B
What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high market capitalization is $5.79B
What is LGND market capitalization year-to-date change?
Ligand Pharmaceuticals Incorporated market capitalization has changed by -$36.77M (-1.80%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, LGND market capitalization has changed by +$548.21M (+37.56%)